Acrivon Therapeutics, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:ACRV) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -19.54 M-16.61 M-12.28 M-15.24 M-20.54 M -64.67 M Cash from investing activities 19.21 M19.45 M5.91 M21.52 M13.13 M 60.01 M Cash from financing activities -343 K-97 K-117 K-192 K-33 K -439 K Free cash flow -19.54 M-16.61 M-12.28 M-15.24 M-20.54 M -64.67 M

News

Acrivon Therapeutics: Priced For Failure, Built For Precision (NASDAQ:ACRV)

Acrivon Therapeutics, Inc. (ACRV) Presents at TD Cowen 46th Annual Health Care Conference - Slideshow (NASDAQ:ACRV) 2026-03-04

Acrivon Therapeutics, Inc. (ACRV) Upgraded to Buy: Here's Why

Jefferies reiterates Acrivon Therapeutics stock rating on trial data

Acrivon to present ACR-368 endometrial cancer data at ESGO congress

Sunday’s Insider Activity: Top Executives Make Strategic Moves

Acrivon Therapeutics CEO Blume-Jensen buys $82k in shares

Acrivon Therapeutics COO Devroe buys $17k in shares

Piper Sandler raises Acrivon Therapeutics stock price target to $8 on positive cancer data

Acrivon Therapeutics stock plunges after mixed cancer trial results

Why Is Acrivon Therapeutics Stock Falling Today? - Acrivon Therapeutics (NASDAQ:ACRV)

Acrivon reports 52% response rate in serous endometrial cancer trial